Figure 3
From: An enhancer peptide for membrane-disrupting antimicrobial peptides
NP4P enhancement of bactericidal activities of AMPs. The dose-effect curves were determined in the presence of NP4P at various concentrations (0, 2.5, 5, 20, and 100 μg/mL). Bactericidal activities were measured against S. aureus IFO12732 for ASABF-α (A) and against E. coli JM109 to polymyxin B (B). Viability is defined as normalized number of viable cells to the number in the absence of ASABF-α or polymyxin B.